HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 15,840
+140 (0.89%)
Mar 20, 2026, 3:30 PM KST
HLB Pharmaceutical Market Cap
HLB Pharmaceutical has a market cap or net worth of 222.43 billion as of March 20, 2026. Its market cap has decreased by -41.66% in one year.
Market Cap
222.43B
Enterprise Value
212.78B
Revenue
36.10B
Ranking
n/a
PE Ratio
470.60
Stock Price
15,840.00
Market Cap Chart
Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 222.43B, an increase of 163.92%. That is a compound annual growth rate of 9.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 222.43B | -1.25% |
| Dec 30, 2025 | 225.24B | -33.44% |
| Dec 30, 2024 | 338.42B | 58.45% |
| Dec 28, 2023 | 213.58B | 43.49% |
| Dec 29, 2022 | 148.85B | -21.48% |
| Dec 30, 2021 | 189.57B | -21.05% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CMG Pharmaceutical | 261.24B |
| Boditech Med | 257.91B |
| Ilyang Pharmaceutical Co.,Ltd | 233.92B |
| Chong Kun Dang Holdings | 233.27B |
| Suheung | 228.50B |
| Samjin Pharmaceuticals | 227.14B |
| Daewon Pharmaceutical | 223.34B |
| Samil Pharmaceutical Co.,Ltd | 213.36B |